MedTrace Logo

Muscle Stimulation in Advanced Idiopathic Pulmonary Fibrosis

NCT03499275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2021-01-07

No results posted yet for this study

Summary

The aims of this study are to determine whether neuromuscular stimulation (NMES) of the quadriceps muscle is acceptable to patients with Idiopathic Pulmonary Fibrosis (IPF) and staff and whether it can impact clinical and healthcare resource usage outcomes.

.

Conditions

Interventions

DEVICE

Active NMES

Neuromuscular electrical stimulation to the quadriceps muscle

DEVICE

Sham NMES

Sham neuromuscular electrical stimulation to the quadriceps muscle

OTHER

Home exercise programme

Home exercise programme. Both arms of the trial receive this intervention.

OTHER

Breathlessness advice

Breathlessness advice. Both arms of the trial receive this intervention.

Sponsors & Collaborators

  • Kings Clinical Trials Unit

    collaborator UNKNOWN

  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Principal Investigators

  • William DC Man, PhD · Royal Brompton and Harefield NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2020-03-31
Completion
2020-08-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03499275 on ClinicalTrials.gov